Get started
Author

Junmei Lin

Observed name: 林俊梅
Observed institution: Jinhua Central Hospital
ORCID: 0009-0000-0285-8930
Observed ORCID: 0009-0000-0285-8930
OpenAlex ID: A5102784026
Mechanism of M2 type macrophage-derived extracellular vesicles regulating PD-L1 expression via the MISP/IQGAP1 axis in hepatocellular carcinoma immunotherapy resistance
2023 · Xiaobo Wang, Xuxing Ye, et al. · International Immunopharmacology · 31
IGF2BP1 accelerates the aerobic glycolysis to boost its immune escape in hepatocellular carcinoma microenvironment
2024 · Xuxing Ye, Junmei Lin, et al. · Frontiers in Immunology · 20
PDF
Exploring the therapeutic mechanisms of Coptidis Rhizoma in gastric precancerous lesions: a network pharmacology approach
2024 · Xuxing Ye, Chao Yang, et al. · Discover Oncology · 7
CAF-EVs carry lncRNA MAPKAPK5-AS1 into hepatocellular carcinoma cells and promote malignant cell proliferation
2024 · Lin Sheng, Junmei Lin, et al. · Communications Biology · 5
PDF
Cell type-resolved analysis identifies LOXL2⁺ fibroblasts as key drivers of malignant stromal remodeling in hepatocellular carcinoma
2026 · Haijun Chen, Lujian Zhu, et al. · Discover Oncology
Hypoxia-driven HIF1A-HK2-dependent glycolytic reprogramming contributes to sorafenib tolerance in hepatocellular carcinoma
2026 · Haijun Chen, Lujian Zhu, et al. · Research Square
PDF
Surgery versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced gastrointestinal tract cancers
2025 · Xuxing Ye, Zhangqiang Wu, et al. · Frontiers in Oncology
PDF
Works count: 8
Citation count: 63
H-index: 4
I10-index: 2
Year
Topic
Type